This is Weave
The Weave Bio AI regulatory platform supports regulatory workflows across modern drug development using AI-native technology. Weave helps regulatory teams navigate evolving global frameworks, including guidance from agencies like the FDA.
At the core of this work, our mission is to equip human experts with the AI tools they need to develop faster, safer, and more affordable treatments for patients. Through regulatory innovation and scientific collaboration, we’re transforming how life-saving therapies reach the people who need them.
At Weave, we set a new standard for regulatory work.
Our AI-native platform supports the entire regulatory content lifecycle, from authoring to publishing and response management.
We believe human expertise is irreplaceable, and technology should amplify it. TThat’s why we built Weave to bring people and AI together and support the work that connects groundbreaking science to the patients who need it. Our platform helps experts prepare and manage complex dossiers faster, more consistently, and with greater confidence.
Scientists, engineers, and regulatory experts founded Weave, with leading investors backing the company and organizations across the life sciences placing their trust in it.. Together, we’re helping teams move faster, work smarter, and focus on the science that matters most.
Meet the team
From our experts to yours

Brandon Rice
Chief Executive Officer

Ari Caroline
Chief Strategy Officer

Umut Eser
Chief AI Officer

Sean Campbell
Chief Operating Officer

Mark Hober
Vice President, Sales

Levi Malot
Chief Technology Officer
Our partners
Transforming regulatory for good